Martin Frotscher
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 27, 2023
Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.Mohamed Salah, Mariam Tahoun, Jeannette Rudzitis-Auth
|Aug 22, 2022
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.Abdelrahman Mohamed, Mohamed Salah, Mariam Tahoun
|Dec 17, 2021
17β-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer.Emanuele M Gargano, Abdelrahman Mohamed, Ahmed S Abdelsamie
|Jul 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.Ahmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger
|Jan 16, 2019
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.Ahmed S Abdelsamie, Steven Herath, Yannik Biskupek
|Nov 28, 2018
Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy.Lorenz Siebenbuerger, Victor Hernandez-Olmos, Ahmed S Abdelsamie
Pageof 2
Frequent Collaborators
5 joint publications
Chris J van Koppen
4 joint publications
Rolf W Hartmann
4 joint publications
Ahmed S Abdelsamie
3 joint publications
Sandrine Marchais-Oberwinkler
3 joint publications
Mohamed Salah
2 joint publications
Mariam Tahoun
1 joint publications
Giuseppe F Mangiatordi
1 joint publications
Orazio Nicolotti
